Arathi S Gadwalkar, Dr Prabhakar K, Srinivasa SV, Dr Maharaj LSYMJ


Background: Serum Ferritin, an acute phase reactant is a marker of iron stores in the body. Recent studies indicate that increased body iron stores
and subclinical hemochromatosis has been associated with the development of glucose intolerance, type 2 diabetes, metabolic syndrome and
possibly the development of diabetic retinopathy, nephropathy and vascular dysfunction. This study was carried out to examine and establish a
relationship between Serum Ferritin with Type 2 diabetes mellitus and metabolic syndrome and to examine whether a correlation between S.
ferritin and FBS, HbA1c exists.
Methods: 173 Subjects satisfying the inclusion and exclusion criteria were selected. S. ferritin, Hb,ESR FBS, PPBS, HbA1c were measured.
Results: Serum ferritin was significantly higher in diabetic patients when compared to controls and serum ferritin had a positive correlation with
increasing duration of diabetes.
Conclusions: Serum Ferritin was higher among cases than in controls group. Positive correlation was observed between HbA1c and Serum
Ferritin among cases. Hence glycemic status is significantly related to serum ferritin levels among diabetics.


Ferritin, Diabetes, FBS

Full Text:



Braunwald M, Fauci. Diabetes Mellitus. In: Harrison's principles of internal medicine.15th Ed. McGraw Hill 2001. p. 3341-4.

Raj S, Rajan GV. Correlation between elevated serum ferritin and HbA1c in type 2 diabetes mellitus. Int J Res Med Sci 2013;1:12-5

Carpenter, Giggs. Diabetes Mellitus.Cecil Essentials of Medicine.19th ed. Saunders.1998. p. 583.

Hramiak IM, Finegood DT, Adams PC. Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med 1997; 20 (2) :110-118. 4. Kim NH. Serum ferritin in healthy subjects and type 2 diabetes mellitus. Med Korea 2000; 41(3): 387-392.

Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004;291:711-7.

Thomas MC, MacIsaac RJ, Tsalamandris C, Jerums G. Elevated iron indices in patients with diabetes. Diabet Med 2004;21:798-802.

Chang JS, Lin SM, Jane CJ, et al. Serum ferritin and risk of Metabolic Syndrom, a population-based study. Asia pac J ClinNutr 2013; 22: 400-407

Burtis CA, Ashwood ER, Bruns DE. Teitz textbook of clinical chemistry and molecular diagnostics 4th ed: New Delhi, Saunders Harcourt. 2006: p.856-859 & p.869-85

Ditzel J, Kajeergaard J. Hemoglobin Alc concentrations after initial insulin

treatment for newly discovered diabetes. Br Med J 1978; I: 741-742

Fernandez-Real JM, rICART-eNGEL W, ArrogoE.Serum ferritin as a component of the insulin resistant syndrom. Diabetes Care 1998; 21(1): 62-

Cantur K Z, Cetinarslay B, Tarkun I, Canturk NZ. Serum ferritin levels in poorly- and well-controlled diabetes mellitus. Endocr Res 2003;29:299-306

Eschwege E, Saddi R, Wacjman H, Levy R, Thibult N, Duchateau A. HaemoglobinAIc in patients on venesection therapy for haemochromatosis. DiabeteMetab 1982;8:137-40

Kaye TB, Guay AT, Simonson DC. Non-insulindependent diabetes mellitus and elevated serum ferritin level. J Diabetes Complications 1993;7:246- 9.

Kwant J. Patients with type 2 diabetes have a high frequency of the C282 mutations of hemochromatosis gene. Clin Invest Med 1998; 21 (6): 251-257.


  • There are currently no refbacks.